PMA device
Exablate Neuro
Insightec · Mr-Guided Focused Ultrasound System (POH, Class III) · First FDA decision Oct 8, 2024, newest Oct 8, 2024Essential tremorParkinson's disease
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
120
Naming "Exablate Neuro"
MAUDE reports
10
Brand "Exablate Neuro", since 2015
PubMed studies
18
Mentioning "Exablate Neuro"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Exablate Neuro
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Exablate Neuro, Exablate Prime, Exablate Transcranial MRgFUS, Exablate Model 4000, Exablate NeuravivePMA supplement
P150038-S036 · Decided Oct 8, 2024 · 174 days after receipt · Normal 180 Day Track
Device type: MR-guided focused ultrasound system (POH) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for TremorProposed local determinationProposedDL37421National Government Services, Inc.Updated Sep 18, 2025
- Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's DiseaseLocal determinationIn effectL37729Noridian Healthcare Solutions, LLCUpdated Sep 2, 2025
Clinical trials
Device studies on ClinicalTrials.gov that name "Exablate Neuro", any status and sponsor, newest update first.
Sunnybrook Health Sciences CentreAcademic, hospital or other
NCT07113665 · 10 participants (planned) · Start Sep 5, 2025 · Primary completion Aug 2028
Device: ExAblate Neuro 4000 · For: Anorexia Nervosa (DSM-IV Revised Criteria)
Sites: Toronto, Canada
Children's National Research InstituteAcademic, hospital or other
NCT07796061 · 45 participants (planned) · Start Dec 2026 · Primary completion Dec 2031
Device: BBB Disruption · For: DMG; DIPG
Sites: Washington D.C., District of Columbia
- Unilateral and Staged Bilateral Pallidothalamic Tractotomy Using Exablate MRgFUS in Advanced Parkinson's Disease.Pivotal-lookingNot yet recruiting
InSightecNot on our public-company list
NCT07764874 · 120 participants (planned) · Start Nov 2026 · Primary completion Dec 2029
Device: Unilateral Exablate MRgFUS Pallidothalamic Tractotomy; Staged Bilateral Exablate Pallidothalamic Tractotomy · For: Parkinson Disease
Sites: Seoul, South Korea
117 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Exablate Neuro", and for the whole product code for context.
This brand
10 reports: 2 malfunction, 7 injury, 1 death
Whole product code POH
262 reports: 2 malfunction, 254 injury, 5 death
Newest reports for this brand
- EXABLATE NEUROInjury
19259551 · Received May 7, 2024 · Event dated Apr 23, 2024
Device type: Mr-Guided Focused Ultrasound System (POH)
Patient problem as coded: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available
- EXABLATE NEUROInjury
19225268 · Received May 1, 2024 · Event dated Mar 28, 2024
Device type: Mr-Guided Focused Ultrasound System (POH)
Patient problem as coded: Fluid Discharge
MW5154162 · Received Apr 23, 2024 · Event dated Feb 9, 2024
Device type: Mr-Guided Focused Ultrasound System (POH)
Patient problem as coded: Cognitive Changes; Decreased Level of Consciousness; Sleepiness/Drowsiness/Somnolence
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Exablate Neuro"[tiab]. The summary above synthesizes these.
- Exablate Neuro for essential tremor.
Med Lett Drugs Ther · 2017
- Device profile of exAblate Neuro 4000, the leading system for brain magnetic resonance guided focused ultrasound technology: an overview of its safety and efficacy in the treatment of medically refractory essential tremor.
Jameel A, Bain P, Nandi D, et al. · Expert Rev Med Devices · 2021Review
- A phase 1 open-label trial evaluating focused ultrasound unilateral anterior thalamotomy for focal onset epilepsy.
Krishna V, Mindel J, Sammartino F, et al. · Epilepsia · 2023Clinical Trial, Phase I, Research Support, Non-U.S. Gov't
- Cavitation monitoring, treatment strategy, and acoustic simulations of focused ultrasound blood-brain barrier disruption in patients with glioblastoma.
McDannold N, Wen PY, Reardon DA, et al. · J Control Release · 2024Research Support, N.I.H., Extramural
- Echo-Focusing in Transcranial Focused Ultrasound Thalamotomy for Essential Tremor: A Feasibility Study.
Jones RM, Huang Y, Meng Y, et al. · Mov Disord · 2020Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- Evaluation of Pseudorandom Sonications for Reducing Cavitation With a Clinical Neurosurgery HIFU Device.
Lafon C, Moore D, Eames MDC, et al. · IEEE Trans Ultrason Ferroelectr Freq Control · 2021Research Support, Non-U.S. Gov't
- Cavitation Feedback Control of Focused Ultrasound Blood-Brain Barrier Opening for Drug Delivery in Patients with Parkinson's Disease.
Huang Y, Meng Y, Pople CB, et al. · Pharmaceutics · 2022
- The Role of Treatment-Related Parameters and Brain Morphology in the Lesion Volume of Magnetic-Resonance-Guided Focused Ultrasound Thalamotomy in Patients with Tremor-Dominant Neurological Conditions.
Morabito R, Cammaroto S, Militi A, et al. · Bioengineering (Basel) · 2024
- Ultra-short time-echo based ray tracing for transcranial focused ultrasound aberration correction in human calvaria.
Manuel TJ, Bancel T, Tiennot T, et al. · Phys Med Biol · 2025
- Characterization of passive permeability after low intensity focused ultrasound mediated blood-brain barrier disruption in a preclinical model.
Arsiwala TA, Sprowls SA, Blethen KE, et al. · Fluids Barriers CNS · 2022
- Evaluation of an MRI receive head coil for use in transcranial MR guided focused ultrasound for functional neurosurgery.
Bitton RR, Sheingaouz E, Assif B, et al. · Int J Hyperthermia · 2021
- Full-wave acoustic and thermal modeling of transcranial ultrasound propagation and investigation of skull-induced aberration correction techniques: a feasibility study.
Kyriakou A, Neufeld E, Werner B, et al. · J Ther Ultrasound · 2015
Other devices of this type
Also filed under product code POH.
- Exablate Model 4000 SystemInsightec · PMA 2026
- Exablate 4000 System Type-1 (i.e. Type 1.0/1.1)Insightec · PMA 2022
- ExAblate Neuro ThalamotomyInsightec · PMA 2017
- Exablate 4000 (Neuro) Type 1.0 & 1.1Insightec · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.